BioNTech

BioNTech signs $425m flu vaccine deal with Pfizer

German biopharmaceutical company BioNTech has signed a research and development (R&D) agreement with Pfizer for the development of mRNA-based vaccines…

BioNTech and Genevant Sciences to develop rare disease drugs

German biopharmaceutical firm BioNTech has partnered with Genevant Sciences, a genetic disorder therapeutics maker, to develop mRNA therapy programmes, which…